FLEMINGTON, N.J.--(BUSINESS WIRE)--NovaDel Pharma Inc. (AMEX: NVD), a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed treatments, reported financial results for its second quarter ended June 30, 2008. For the quarter ended June 30, 2008, NovaDel reported a net loss of $3.2 million, or $0.05 per share, compared to a net loss of $5.3 million, or $0.09 per share, for the quarter ended June 30, 2007. For the six months ended June 30, 2008, the Company reported a net loss of $5.2 million, or $0.09 per share, as compared to a net loss of $10.7 million, or $0.18 per share for the six months ended June 30, 2007.
